Literature DB >> 33641611

Uremic serum induces prothrombotic changes in venous endothelial cells and inflammatory changes in aortic endothelial cells.

Patrycja Sosińska-Zawierucha1, Andrzej Bręborowicz1.   

Abstract

BACKGROUND: Uremia induces various pathologic changes in the endothelium. However, there is limited information about the differences of these effects in endothelial cells originating from different parts of the vascular tree.
METHODS: The effect of uremic serum obtained from patients with end stage renal failure on the gene expression and secretory activity of venous endothelial cells (VEC) and aortic endothelial cells (AEC) was studied in in vitro culture.
RESULTS: In VEC, the expression of genes regulating the synthesis of von Willebrand factor (vWF) was increased by 254% (p<.005), vascular endothelial growth factor (VEGF) synthesis by 150% (p<.001), tissue plasminogen activator (t-PA) synthesis by 62% (p<.005), platelet endothelial cell adhesion molecule by 89% (p<.005), and the expression of gene regulating interleukin-6 (IL-6) synthesis was reduced. In AEC, the expression of the gene regulating synthesis of IL-6 was increased by 174% (p<.001), and the expression of the other genes was reduced. The secretion of IL-6 was reduced in VEC by 38% (p<.01) and increased in AEC by 55% (p<.005). In VEC, increased synthesis of VEGF 64% (p<.001) vWF (+34%, p<.01), and t-PA (+53%, p<.002) was observed, and in AEC it was reduced.
CONCLUSIONS: VEC and AEC respond in different ways after exposure to uremic serum. VEC acquires the prothrombotic phenotype, whereas in AEC the inflammatory phenotype appears.

Entities:  

Keywords:  Aortic endothelium; inflammation; thrombosis; uremia; venous endothelium

Mesh:

Substances:

Year:  2021        PMID: 33641611      PMCID: PMC7928024          DOI: 10.1080/0886022X.2021.1890617

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Differences in secretion of prostacyclin by venous and arterial endothelial cells grown in vitro in a static versus a mechanically active environment.

Authors:  G R Upchurch; A J Banes; W H Wagner; F Ramadan; G W Link; R H Henderson; G Johnson
Journal:  J Vasc Surg       Date:  1989-09       Impact factor: 4.268

3.  Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.

Authors:  Bakhtawar K Mahmoodi; Ron T Gansevoort; Inger Anne Næss; Pamela L Lutsey; Sigrid K Brækkan; Nic J G M Veeger; Ellen E Brodin; Karina Meijer; Yingying Sang; Kunihiro Matsushita; Stein I Hallan; Jens Hammerstrøm; Suzanne C Cannegieter; Brad C Astor; Josef Coresh; Aaron R Folsom; John-Bjarne Hansen; Mary Cushman
Journal:  Circulation       Date:  2012-09-13       Impact factor: 29.690

4.  Cellular senescence determines endothelial cell damage induced by uremia.

Authors:  Julia Carracedo; Paula Buendía; Ana Merino; Sagrario Soriano; Elvira Esquivias; Alejandro Martín-Malo; Pedro Aljama; Rafael Ramírez
Journal:  Exp Gerontol       Date:  2013-04-25       Impact factor: 4.032

5.  Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells.

Authors:  Rossella Alinovi; Matteo Goldoni; Silvana Pinelli; Marco Campanini; Irene Aliatis; Danilo Bersani; Pier Paolo Lottici; Sergio Iavicoli; Marta Petyx; Paola Mozzoni; Antonio Mutti
Journal:  Toxicol In Vitro       Date:  2014-12-16       Impact factor: 3.500

6.  Flow-mediated vasodilation in end-stage renal disease.

Authors:  Francis H Verbeke; Bruno Pannier; Alain P Guérin; Pierre Boutouyrie; Stephane Laurent; Gérard M London
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

7.  Sulodexide Reduces the Proinflammatory Effect of Serum from Patients with Peripheral Artery Disease in Human Arterial Endothelial Cells.

Authors:  Patrycja Sosińska; Ewa Baum; Beata Maćkowiak; Magdalena Maj; Katarzyna Sumińska-Jasińska; Ryszard Staniszewski; Andrzej Bręborowicz
Journal:  Cell Physiol Biochem       Date:  2016-12-12

8.  Pulmonary embolism in patients with CKD and ESRD.

Authors:  Gagan Kumar; Ankit Sakhuja; Amit Taneja; Tilottama Majumdar; Jayshil Patel; Jeff Whittle; Rahul Nanchal
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-26       Impact factor: 8.237

Review 9.  Arterial versus venous endothelial cells.

Authors:  Nathaniel G dela Paz; Patricia A D'Amore
Journal:  Cell Tissue Res       Date:  2008-10-30       Impact factor: 5.249

10.  Damage of the endothelial glycocalyx in dialysis patients.

Authors:  Carmen A Vlahu; Bregtje A Lemkes; Dirk G Struijk; Marion G Koopman; Raymond T Krediet; Hans Vink
Journal:  J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 10.121

View more
  2 in total

1.  Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.

Authors:  Monika Misian; Ewa Baum; Andrzej Bręborowicz
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

2.  Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience.

Authors:  Sunnesh Reddy Anapalli; Harini Devi N; Pvgk Sarma; Lokanathan Srikanth; Siva Kumar V
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.